To help mit­i­gate struc­tur­al dis­ad­van­tage, the National Academies of Science, Engineering and Medicine (NASEM) frame­work for equi­tably allo­cat­ing COVID-19 vac­cines pro­posed increas­ing allo­ca­tions to worse-off minori­ties through the CDC’s Social Vulnerability Index (SVI). However, the extent of ben­e­fit is unknown. Moreover, since SVI includes a race vari­able and could face legal chal­lenges, it is desir­able to […]

Mayara Felix eval­u­ates the impact of Massachusetts Chapter 222—a pol­i­cy that lim­it­ed char­ter schools’ abil­i­ty to sus­pend students—on stu­dent sus­pen­sions and test scores. Comparing char­ter atten­dance effects before vs. after Chapter 222, she find that Chapter 222 reduced char­ter sus­pen­sions by rough­ly 10 per­cent­age points, but had no impact on char­ter learn­ing. The author then […]

How should we decide which pop­u­la­tion groups receive Covid-19 vac­cines before oth­ers? Harald Schmidt, Parag Pathak, Tayfun Sönmez, and M Utku Ünver exam­ine the exist­ing frame­works and argue that pri­or­i­tiz­ing worse-off groups is urgent, jus­ti­fied, and feasible.